New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 28, 2012
13:39 EDTCADXCadence settlement for Ofirmev a positive, says Deutsche Bank
Deutsche Bank views Cadence's (CADX) settlement with Perrigo (PRGO) regarding its pain management product Ofirmev as a very positive development since it could provide the company a longer than expected runway to fully benefit from Ofirmevís projected cash flow. Deutsche now sees an increased likelihood that Cadence resolves Exela's patent challenge in the coming months and keeps a Buy rating on Cadence.
News For CADX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for CADX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use